Cargando…

Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding

Botulinum neurotoxins (BoNTs) are a family of highly dangerous bacterial toxins, with seven major serotypes (BoNT/A-G). Members of BoNTs, BoNT/A1 and BoNT/B1, have been utilized to treat an increasing number of medical conditions. The clinical trials are ongoing for BoNT/A2, another subtype of BoNT/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gustafsson, Robert, Zhang, Sicai, Masuyer, Geoffrey, Dong, Min, Stenmark, Pål
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923319/ https://www.ncbi.nlm.nih.gov/pubmed/29649119 http://dx.doi.org/10.3390/toxins10040153

Ejemplares similares

Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors
por: Davies, Jonathan R., et al.
Publicado: (2020)

Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E
por: Masuyer, Geoffrey, et al.
Publicado: (2021)

Identification and characterization of a novel botulinum neurotoxin
por: Zhang, Sicai, et al.
Publicado: (2017)

Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity
por: Masuyer, Geoffrey, et al.
Publicado: (2018)

N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
por: Yao, Guorui, et al.
Publicado: (2016)

Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy
por: Yin, Linxiang, et al.
Publicado: (2020)

Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models
por: Elliott, Mark, et al.
Publicado: (2019)

Structure of dual receptor binding to botulinum neurotoxin B
por: Berntsson, Ronnie P-A, et al.
Publicado: (2013)

Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM
por: Košenina, Sara, et al.
Publicado: (2021)

Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors
por: Peng, Lisheng, et al.
Publicado: (2011)

Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
por: Weisemann, Jasmin, et al.
Publicado: (2016)

Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC
por: Zhang, Sicai, et al.
Publicado: (2017)

Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction
por: Stenmark, Pål, et al.
Publicado: (2008)

Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
por: Tao, Liang, et al.
Publicado: (2017)

Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside
por: Gregory, Kyle S., et al.
Publicado: (2022)

Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons
por: Yiangou, Yiangos, et al.
Publicado: (2011)

High resolution crystal structures of the receptor-binding domain of Clostridium botulinum neurotoxin serotypes A and FA
por: Davies, Jonathan R., et al.
Publicado: (2018)

A neurotoxin that specifically targets Anopheles mosquitoes
por: Contreras, Estefania, et al.
Publicado: (2019)

Botulinum Neurotoxin Devoid of Receptor Binding Domain Translocates Active Protease
por: Fischer, Audrey, et al.
Publicado: (2008)

Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H
por: Yao, Guorui, et al.
Publicado: (2017)

Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
por: Gregory, Kyle S., et al.
Publicado: (2020)

Structural analysis of Clostridium botulinum neurotoxin type D as a platform for the development of targeted secretion inhibitors
por: Masuyer, Geoffrey, et al.
Publicado: (2015)

Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2
por: Liu, Zheng, et al.
Publicado: (2023)

Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C
por: Benoit, Roger M., et al.
Publicado: (2017)

SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons
por: Yeh, Felix L., et al.
Publicado: (2010)

Transient Receptor Potential Channels and Botulinum Neurotoxins in Chronic Pain
por: Go, Eun Jin, et al.
Publicado: (2021)

High Cell Density Cultivation Process for the Expression of Botulinum Neurotoxin a Receptor Binding Domain
por: Ben David, Alon, et al.
Publicado: (2022)

Bioinformatic discovery of a toxin family in Chryseobacterium piperi with sequence similarity to botulinum neurotoxins
por: Mansfield, Michael James, et al.
Publicado: (2019)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding
por: Yao, Guorui, et al.
Publicado: (2017)

Small Molecule Receptor Binding Inhibitors with In Vivo Efficacy against Botulinum Neurotoxin Serotypes A and E
por: Ben David, Alon, et al.
Publicado: (2021)

Knockin mouse models demonstrate differential contributions of synaptotagmin-1 and -2 as receptors for botulinum neurotoxins
por: Thaker, Hatim, et al.
Publicado: (2021)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3
por: Leka, Oneda, et al.
Publicado: (2021)

Potent Neutralization of Botulinum Neurotoxin/B by Synergistic Action of Antibodies Recognizing Protein and Ganglioside Receptor Binding Domain
por: Chen, Changchun, et al.
Publicado: (2012)

Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics
por: Davies, Jonathan R., et al.
Publicado: (2018)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a4dn15i0kc8vf4h5a4e6f7hts3